IndraLab
Statements
reach
"Cutaneous melanoma, melanocytic tumors and other skin tumors:.
The frequency of cutaneous melanoma (CM) development is likely to increase with germline BAP1 mutations and tumor-promoting effects of these BAP1 mutations are strongly influenced by co-occurrence of associated oncogenes such as mutant BRAF (2,43)."